Fertility preservation in female classic galactosemia patients
نویسندگان
چکیده
Almost every female classic galactosemia patient develops primary ovarian insufficiency (POI) as a diet-independent complication of the disease. This is a major concern for patients and their parents, and physicians are often asked about possible options to preserve fertility. Unfortunately, there are no recommendations on fertility preservation in this group. The unique pathophysiology of classic galactosemia with a severely reduced follicle pool at an early age requires an adjusted approach. In this article recommendations for physicians based on current knowledge concerning galactosemia and fertility preservation are made. Fertility preservation is only likely to be successful in very young prepubertal patients. In this group, cryopreservation of ovarian tissue is currently the only available technique. However, this technique is not ready for clinical application, it is considered experimental and reduces the ovarian reserve. Fertility preservation at an early age also raises ethical questions that should be taken into account. In addition, spontaneous conception despite POI is well described in classic galactosemia. The uncertainty surrounding fertility preservation and the significant chance of spontaneous pregnancy warrant counseling towards conservative application of these techniques. We propose that fertility preservation should only be offered with appropriate institutional research ethics approval to classic galactosemia girls at a young prepubertal age.
منابع مشابه
I-33: Current Methods for Fertility Preservation
Background Increasing survival rates in patients who suffer from oncological disease and improvement in reproductive medicine techniques has led to increasing use of different fertility preservation methods. The evidence supporting current and forthcoming options for fertility preservation consisted of two main parts as for female and male. Fertility preservation options for female and male dep...
متن کاملI-22: Fertility Preservation and Ovarian Stimulation in Cancer Patients
Cancer is not uncommon and no longer considered to be an incurable disorder. 10% of cancer cases occur under the age of 45. There is a remarkable improvement in treatment and survival rates. Today women have been delaying initiation of childbearing because the incidence of most cancers increases with age. Delayed childbearing results in more female cancer survivors. As a consequence there is an...
متن کاملI-35: Emergency Stimulation for Onco -Fertility Patients
Background Fertility preservation for female cancer patients prior to cancer therapy has emerged as an essential component of comprehensive patient care. In the US, approximately 6% of women diagnosed with invasive cancer between 2007 and 2011 that were under 45 years old. The incidence of cancers in reproductive age women signifies a need for fertility preservation options and this need is inc...
متن کاملI-11: Optimal Strategy Toward Fertility Preservation
Background There are several indications of human female gamete cryostorage including sub-fertile and fertile patients. But our focus will be in women at risk of losing their reproductive function caused by oncologycal treatments or premature ovarian failure that could benefit greatly from this practice. Fertile women may take advantage of this technology to electively delay childbearing. The o...
متن کاملFemale fertility preservation: practical and ethical considerations of an underused procedure.
PURPOSE Cancer treatments for young women can permanently or temporarily affect fertility. The purpose of this retrospective analysis was to present the clinical experience and ethical considerations of fertility preservation in female oncology patients in a tertiary gynaecological department. METHODS Since 2002, in 37 patients fertility preservation was performed according to an institutiona...
متن کامل